Back

The prevalence of cardiotropic viruses among the Polish population with viral heart disease

12 May 2024 (11:40 - 13:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - epidemiology, prognosis, outcome 4 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Agnieszka Pawlak

Pimmswia, Warsaw (Poland)

5 More presentations in this session

Presentation thumbnail
Comparative analysis of clinical adverse outcomes in cardiac resynchronization therapy: transvenous lead vs epicardial lead
Doctor L. Pinheiro (Guimaraes, PT)
Abstract Slides Video
Presentation thumbnail
Proteomic analysis of potential biomarkers of recent onset dilated cardiomyopathy for prediction of the therapy outcome
Professor R. Pudil (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Differential effect of sex on mortality according to age in heart failure
Associate Professor J. Park (Seongnam, KR)
Abstract Slides Video
Presentation thumbnail
Predicting worsening heart failure events: a novel prediction model - a single centre analysis
Doctor C. Miguel Goncalves (Leiria, PT)
Abstract Slides Video
Presentation thumbnail
Heart failure disparities by sex: a comparative analysis of a real-world population in a regional hospital
Doctor A. Fonseca Vazao (Leiria, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - epidemiology, prognosis, outcome 4

The Event

Event poster

Heart Failure 2024

12 May 2024 11:40 CET
You may be interested in
thumbnail
Congress Presentation
Estimation of the virus association in arrhythmias in people with viral heart disease
thumbnail
Congress Presentation
Histological profiling, viral analysis, and follow-up of inflammatory cardiomyopathy in adults supported by long-term left ventricular assist device therapy
thumbnail
Congress Presentation
Changes in myocardial inflammation and viral infection in adults with inflammatory cardiomyopathy following long-term left ventricular assist device

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources